BIOMAT Database Logo BIOMAT Database Logo

Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. 1988

D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
Department of Surgery, General Hospital, Malmö, Sweden.

A prospective randomized double-blind trial was performed comparing conventional low-dose heparin with a low molecular weight heparin fragment for thromboprophylaxis in elective general abdominal surgical patients. The first dose of the heparin fragment was given the evening before surgery, and further doses were given thereafter every evening. There were 1002 analysable patients, 826 having received correct prophylaxis. Of these 1002 patients, 64 per cent were operated on for malignant disease. A total of 20 patients died, 10 in each group. The frequency of deep vein thrombosis was significantly reduced among patients with correct prophylaxis with the heparin fragment (9.2-5.0 per cent, P = 0.02) [corrected]. The frequency of bleeding was 6.7 per cent among the heparin fragment patients and 2.7 per cent among the patients given conventional heparin (P = 0.01), but all bleeds were of minor degree and there was no difference in the reoperation rate for bleeding, or in the transfusion requirements. Local pain at the injection site was reported significantly less often among patients given the heparin fragment.

UI MeSH Term Description Entries
D007431 Intraoperative Complications Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure. Peroperative Complications,Surgical Injuries,Complication, Intraoperative,Complication, Peroperative,Injuries, Surgical,Complications, Intraoperative,Complications, Peroperative,Injury, Surgical,Intraoperative Complication,Peroperative Complication,Surgical Injury
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis.
February 1988, The British journal of surgery,
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
[Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin].
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
[Thrombosis prevention with low molecular weight heparin].
July 1987, Medizinische Monatsschrift fur Pharmazeuten,
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis.
March 1986, The British journal of surgery,
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
[Prevention of thrombosis with low molecular weight heparin in gynecology].
January 1995, Zentralblatt fur Gynakologie,
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.
June 1992, Thrombosis and haemostasis,
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
[Prevention of thrombosis with low molecular weight heparin and hydroxyethyl starch in general surgery].
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
Low molecular weight heparin in prevention of perioperative thrombosis.
October 1992, BMJ (Clinical research ed.),
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
[Prevention of thrombosis with unfractionated and low molecular weight heparin].
December 1989, Wiener medizinische Wochenschrift (1946),
D Bergqvist, and T Mätzsch, and U S Burmark, and J Frisell, and O Guilbaud, and T Hallböök, and A Horn, and A Lindhagen, and H Ljungnér, and K G Ljungström
[Thrombosis prevention with low dose heparin].
March 1977, Ugeskrift for laeger,
Copied contents to your clipboard!